Atlas Trials

Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder

Clinical trial NCT06673394 · WITHDRAWN

Trial details

NCT number
NCT06673394
Sponsor
Tianjin Medical University General Hospital
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neuromyelitis Optica Spectrum Disorder Attack
Start date
2025-09-03
Primary completion
2026-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.